A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity
Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers

besthealthtale.com
Home ยป
A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity